Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 Dec;98(4):1383–1391. doi: 10.1111/j.1476-5381.1989.tb12688.x

Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats.

M Katori 1, M Majima 1, R Odoi-Adome 1, N Sunahara 1, Y Uchida 1
PMCID: PMC1854808  PMID: 2692754

Abstract

1. In vitro incubation of normal rat plasma with endotoxin from E. coli (3-10 mg ml-1) in the incubation mixture) caused a dose-dependent increase in levels of free kinin and plasma kallikrein in the presence of o-phenanthroline, together with a mirror-image, dose-dependent decrease in the residual levels of the precursors, plasma prekallikrein and high-molecular-weight kininogen. Low-molecular-weight kininogen levels were not modified. 2. Intravenous injection of endotoxin (3-30 mg kg-1) into the femoral vein of anaesthetized rats resulted in dose-dependent hypotension. In blood collected up to 15 min after injection, the levels of prekallikrein and high-molecular-weight kininogen in plasma were decreased while levels of the active forms, plasma kallikrein and free kinin, showed a transient increase in the blood 1 min after administration of endotoxin. 3. A degradation product of bradykinin, des-Phe8-Arg9-bradykinin, as measured by a newly developed enzyme immunoassay, was detectable up to 5 min after administration of endotoxin. 4. Intravenous infusion of soybean trypsin inhibitor inhibited both the formation of bradykinin and des-Phe8-Arg9-bradykinin and the initial hypotension. 5. It can be concluded from our results that plasma prekallikrein is activated in the blood immediately after administration of endotoxin to rats and that bradykinin is a major cause of the immediate hypotension.

Full text

PDF
1383

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aasen A. O., Smith-Erichsen N., Amundsen E. Plasma kallikrein-kinin system in septicemia. Arch Surg. 1983 Mar;118(3):343–346. doi: 10.1001/archsurg.1983.01390030075012. [DOI] [PubMed] [Google Scholar]
  2. Adnot S., Lefort J., Lagente V., Braquet P., Vargaftig B. B. Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig. Pharmacol Res Commun. 1986 Aug;18 (Suppl):197–200. doi: 10.1016/0031-6989(86)90052-4. [DOI] [PubMed] [Google Scholar]
  3. Anderson F. L., Jubiz W., Tsagaris T. J., Kuida H. Endotoxin-induced prostaglandin E and F release in dogs. Am J Physiol. 1975 Feb;228(2):410–414. doi: 10.1152/ajplegacy.1975.228.2.410. [DOI] [PubMed] [Google Scholar]
  4. Baue A. E. Recent developments in the stuy and treatment of shock. Surg Gynecol Obstet. 1968 Oct;127(4):849–878. [PubMed] [Google Scholar]
  5. CHIEN S., DELLENBACK R. J., USAMI S., GREGERSEN M. I. HEMATOCRIT CHANGES IN ENDOTOXIN SHOCK. Proc Soc Exp Biol Med. 1965 Apr;118:1182–1187. doi: 10.3181/00379727-118-30075. [DOI] [PubMed] [Google Scholar]
  6. Caridis D. T., Reinhold R. B., Woodruff P. W., Fine J. Endotoxaemia in man. Lancet. 1972 Jun 24;1(7765):1381–1385. doi: 10.1016/s0140-6736(72)91108-7. [DOI] [PubMed] [Google Scholar]
  7. Casals-Stenzel J. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. Eur J Pharmacol. 1987 Mar 17;135(2):117–122. doi: 10.1016/0014-2999(87)90602-9. [DOI] [PubMed] [Google Scholar]
  8. Erdös E. G., Miwa I. Effect of endotoxin shock on the plasma kallikrein-kinin system of the rabbit. Fed Proc. 1968 Jan-Feb;27(1):92–95. [PubMed] [Google Scholar]
  9. Gallimore M. J., Aasen A. O., Lyngaas K. H., Larsbraaten M., Amundsen E. Falls in plasma levels of prekallikrein, high molecular weight kininogen, and kallikrein inhibitors during lethal endotoxin shock in dogs. Thromb Res. 1978 Feb;12(2):307–318. doi: 10.1016/0049-3848(78)90301-8. [DOI] [PubMed] [Google Scholar]
  10. HINSHAW L. B., JORDAN M. M., VICK J. A. Mechanism of histamine release in endotoxin shock. Am J Physiol. 1961 May;200:987–989. doi: 10.1152/ajplegacy.1961.200.5.987. [DOI] [PubMed] [Google Scholar]
  11. Högström H., Claeson G., Larsson-Backström C., Lundberg D., Wenngren E., Haglund U. Septic shock in the rat: activation of plasma proteolytic systems and effects of a kallikrein inhibitor/bradykinin antagonist (S-2441). Acta Chir Scand. 1987 Mar;153(3):161–164. [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Lillehei R. C., Dietzman R. H., Movsas S., Bloch J. H. Treatment of septic shock. Mod Treat. 1967 Mar;4(2):321–346. [PubMed] [Google Scholar]
  14. McConn R., Wasserman F., Haberland G. The kallikrein-kinin system in the acutely-ill: (A) changes in plasma kininogen in acutely-ill patients. (B) the efficacy of pulmonary clearance of bradykinin. Adv Exp Med Biol. 1983;156(Pt B):1019–1035. [PubMed] [Google Scholar]
  15. Morita T., Kato H., Iwanaga S., Takada K., Kimura T. New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase. J Biochem. 1977 Nov;82(5):1495–1498. doi: 10.1093/oxfordjournals.jbchem.a131840. [DOI] [PubMed] [Google Scholar]
  16. Morrison D. C., Cochrane C. G. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J Exp Med. 1974 Sep 1;140(3):797–811. doi: 10.1084/jem.140.3.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nies A. S., Forsyth R. P., Williams H. E., Melmon K. L. Contribution of kinins to endotoxin shock in unanesthetized Rhesus monkeys. Circ Res. 1968 Feb;22(2):155–164. doi: 10.1161/01.res.22.2.155. [DOI] [PubMed] [Google Scholar]
  18. Oh-ishi S., Katori M. Fluorometric assay for plasma prekallikrein using peptidymethyl-coumarinyl-amide as a substrate. Thromb Res. 1979;14(4-5):551–559. doi: 10.1016/0049-3848(79)90111-7. [DOI] [PubMed] [Google Scholar]
  19. ROSENBERG J. C., LILLEHEI R. C., LONGERBEAM J., ZIMMERMANN B. Studies on hemorrhagic and endotoxin shock in relation to vasomotor changes and endogenous circulating epinephrine, norepinephrine and serotonin. Ann Surg. 1961 Oct;154:611–628. doi: 10.1097/00000658-196110000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Robinson J. A., Klondnycky M. L., Loeb H. S., Racic M. R., Gunnar R. M. Endotoxin, prekallikrein, complement and systemic vascular resistance. Sequential measurements in man. Am J Med. 1975 Jul;59(1):61–67. doi: 10.1016/0002-9343(75)90322-8. [DOI] [PubMed] [Google Scholar]
  21. Sardesal V. M., Rosenberg J. C. Proteolysis and bradykinin turnover in endotoxin shock. J Trauma. 1974 Nov;14(11):945–949. doi: 10.1097/00005373-197411000-00006. [DOI] [PubMed] [Google Scholar]
  22. Terashita Z., Imura Y., Nishikawa K., Sumida S. Is platelet activating factor (PAF) a mediator of endotoxin shock? Eur J Pharmacol. 1985 Feb 26;109(2):257–261. doi: 10.1016/0014-2999(85)90427-3. [DOI] [PubMed] [Google Scholar]
  23. Uchida Y., Katori M. Differential assay method for high molecular weight and low molecular weight kininogens. Thromb Res. 1979;15(1-2):127–134. doi: 10.1016/0049-3848(79)90058-6. [DOI] [PubMed] [Google Scholar]
  24. Uchida Y., Majima M., Katori M. A method of determination of human plasma HMW and LMW kininogen levels by bradykinin enzyme immunoassay. Pharmacol Res Commun. 1986 Sep;18(9):831–846. doi: 10.1016/0031-6989(86)90133-5. [DOI] [PubMed] [Google Scholar]
  25. Uchida Y., Tanaka K., Harada Y., Ueno A., Katori M. Activation of plasma kallikrein-kinin system and its significant role in pleural fluid accumulation of rat carrageenin-induced pleurisy. Inflammation. 1983 Jun;7(2):121–131. doi: 10.1007/BF00917817. [DOI] [PubMed] [Google Scholar]
  26. Ueno A., Oh-ishi S., Kitagawa T., Katori M. Enzyme immunoassay of bradykinin using beta-D-galactosidase as a labeling enzyme. Biochem Pharmacol. 1981 Jun 15;30(12):1659–1664. doi: 10.1016/0006-2952(81)90394-4. [DOI] [PubMed] [Google Scholar]
  27. Vick J. A., Mehlman B., Heiffer M. H. Early histamine release and death due to endotoxin. Proc Soc Exp Biol Med. 1971 Jul;137(3):902–906. doi: 10.3181/00379727-137-35690. [DOI] [PubMed] [Google Scholar]
  28. Weipert J., Hoffmann H., Siebeck M., Whalley E. T. Attenuation of arterial blood pressure fall in endotoxin shock in the rat using the competitive bradykinin antagonist Lys-Lys-[Hyp2, Thi5,8, DPhe7]-Bk (B4148). Br J Pharmacol. 1988 Jun;94(2):282–284. doi: 10.1111/j.1476-5381.1988.tb11526.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES